# United Bancshares Inc: financial statements, quarterly

UBOH · OTC · CIK 1087456 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uboh.md) · [Financials](/companies/uboh/financials.md) · [Filings](/companies/uboh/filings.md) · [Insiders](/companies/uboh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uboh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | Q4 FY2020 (2020-12-31) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q4 FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [2,108](/filings/0001437749-21-010761.md) | [1,492](/filings/0001437749-21-018379.md) | [1,702](/filings/0001437749-21-024933.md) | [1,686 d](/filings/0001437749-23-006386.md) | [835](/filings/0001437749-22-011352.md) | [813](/filings/0001437749-22-020159.md) | [745](/filings/0001437749-22-026222.md) | [675 d](/filings/0001437749-23-006386.md) | [563](/filings/0001437749-22-011352.md) | [571](/filings/0001437749-22-020159.md) | [797](/filings/0001437749-22-026222.md) | [1,327 d](/filings/0001437749-23-006386.md) |
| Income tax | $k | [110](/filings/0001437749-21-010761.md) | [1,334](/filings/0001437749-21-018379.md) | [1,208](/filings/0001437749-21-024933.md) | [270 d](/filings/0001437749-23-006386.md) | [873](/filings/0001437749-22-011352.md) | [484](/filings/0001437749-22-020159.md) | [843](/filings/0001437749-22-026222.md) | [294 d](/filings/0001437749-23-006386.md) | [364](/filings/0001437749-22-011352.md) | [174](/filings/0001437749-22-020159.md) | [201](/filings/0001437749-22-026222.md) | [475 d](/filings/0001437749-23-006386.md) |
| Net income | $k | [1,088](/filings/0001437749-22-005332.md) | [5,668](/filings/0001437749-22-005332.md) | [5,250](/filings/0001437749-22-005332.md) | [1,749](/filings/0001437749-22-005332.md) | [4,117](/filings/0001437749-23-006386.md) | [2,655](/filings/0001437749-23-006386.md) | [4,092](/filings/0001437749-23-006386.md) | [2,717](/filings/0001437749-23-006386.md) | [2,520](/filings/0001437749-23-006386.md) | [2,170](/filings/0001437749-23-006386.md) | [3,086](/filings/0001437749-23-006386.md) | [3,534](/filings/0001437749-23-006386.md) |
| Diluted EPS | $ per share | [0.32](/filings/0001437749-22-005332.md) | [1.71](/filings/0001437749-22-005332.md) | [1.60](/filings/0001437749-22-005332.md) | [0.53](/filings/0001437749-22-005332.md) | [1.24](/filings/0001437749-23-006386.md) | [0.80](/filings/0001437749-23-006386.md) | [1.22](/filings/0001437749-23-006386.md) | [0.81](/filings/0001437749-23-006386.md) | [0.76](/filings/0001437749-23-006386.md) | [0.65](/filings/0001437749-23-006386.md) | [0.94](/filings/0001437749-23-006386.md) | [1.10](/filings/0001437749-23-006386.md) |
| Basic EPS | $ per share | [0.33](/filings/0001437749-22-005332.md) | [1.73](/filings/0001437749-22-005332.md) | [1.61](/filings/0001437749-22-005332.md) | [0.54](/filings/0001437749-22-005332.md) | [1.26](/filings/0001437749-23-006386.md) | [0.81](/filings/0001437749-23-006386.md) | [1.24](/filings/0001437749-23-006386.md) | [0.83](/filings/0001437749-23-006386.md) | [0.77](/filings/0001437749-23-006386.md) | [0.66](/filings/0001437749-23-006386.md) | [0.94](/filings/0001437749-23-006386.md) | [1.10](/filings/0001437749-23-006386.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | FY2020 (2020-12-31) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | FY2022 (2022-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [44.8](/filings/0001437749-21-010761.md) | [68.8](/filings/0001437749-21-018379.md) | [29.8](/filings/0001437749-21-024933.md) | [57.0](/filings/0001437749-23-006386.md) | [97.9](/filings/0001437749-21-010761.md) | [120](/filings/0001437749-21-018379.md) | [121](/filings/0001437749-21-024933.md) | [75.2](/filings/0001437749-23-006386.md) | not reported | not reported | not reported | [30.7](/filings/0001437749-23-006386.md) |
| Total assets | $m | [902](/filings/0001437749-20-010101.md) | [1,014](/filings/0001437749-20-016525.md) | [993](/filings/0001437749-20-022120.md) | [979](/filings/0001437749-22-005332.md) | [1,027](/filings/0001437749-21-010761.md) | [1,049](/filings/0001437749-21-018379.md) | [1,070](/filings/0001437749-21-024933.md) | [1,077](/filings/0001437749-23-006386.md) | [1,069](/filings/0001437749-22-011352.md) | [1,111](/filings/0001437749-22-020159.md) | [1,059](/filings/0001437749-22-026222.md) | [1,087](/filings/0001437749-23-006386.md) |
| Total liabilities | $m | [804](/filings/0001437749-20-010101.md) | [909](/filings/0001437749-20-016525.md) | [884](/filings/0001437749-20-022120.md) | [867](/filings/0001437749-22-005332.md) | [915](/filings/0001437749-21-010761.md) | [934](/filings/0001437749-21-018379.md) | [954](/filings/0001437749-21-024933.md) | [957](/filings/0001437749-23-006386.md) | [970](/filings/0001437749-22-011352.md) | [1,024](/filings/0001437749-22-020159.md) | [985](/filings/0001437749-22-026222.md) | [1,005](/filings/0001437749-23-006386.md) |
| Shareholders' equity | $m | [98.5](/filings/0001437749-21-018379.md) | [105](/filings/0001437749-21-024933.md) | [109](/filings/0001437749-21-024933.md) | [112](/filings/0001437749-23-006386.md) | [112](/filings/0001437749-22-020159.md) | [116](/filings/0001437749-22-026222.md) | [116](/filings/0001437749-22-026222.md) | [119](/filings/0001437749-23-006386.md) | [99.4](/filings/0001437749-22-020159.md) | [87.1](/filings/0001437749-22-026222.md) | [73.8](/filings/0001437749-22-026222.md) | [82.7](/filings/0001437749-23-006386.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | Q4 FY2020 (2020-12-31) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q4 FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.5)](/filings/0001437749-21-010761.md) | [(0.2) d](/filings/0001437749-21-018379.md) | [(9.0) d](/filings/0001437749-21-024933.md) | [27.9 d](/filings/0001437749-23-006386.md) | [3.5](/filings/0001437749-22-011352.md) | [4.1 d](/filings/0001437749-22-020159.md) | [7.2 d](/filings/0001437749-22-026222.md) | [11.7 d](/filings/0001437749-23-006386.md) | [(1.7)](/filings/0001437749-22-011352.md) | [7.8 d](/filings/0001437749-22-020159.md) | [3.1 d](/filings/0001437749-22-026222.md) | [7.6 d](/filings/0001437749-23-006386.md) |
| Capital expenditure | $m | [0.0](/filings/0001437749-21-010761.md) | [0.1 d](/filings/0001437749-21-018379.md) | [0.4 d](/filings/0001437749-21-024933.md) | [1.1 d](/filings/0001437749-23-006386.md) | [0.1](/filings/0001437749-22-011352.md) | [0.2 d](/filings/0001437749-22-020159.md) | [0.0 d](/filings/0001437749-22-026222.md) | [3.7 d](/filings/0001437749-23-006386.md) | [0.1](/filings/0001437749-22-011352.md) | [2.7 d](/filings/0001437749-22-020159.md) | [0.3 d](/filings/0001437749-22-026222.md) | [0.5 d](/filings/0001437749-23-006386.md) |
| Dividends paid | $m | [0.5](/filings/0001437749-21-010761.md) | [0.2 d](/filings/0001437749-21-018379.md) | [0.5 d](/filings/0001437749-21-024933.md) | [0.5 d](/filings/0001437749-23-006386.md) | [0.5](/filings/0001437749-22-011352.md) | [0.6 d](/filings/0001437749-22-020159.md) | [0.7 d](/filings/0001437749-22-026222.md) | [0.7 d](/filings/0001437749-23-006386.md) | [0.7](/filings/0001437749-22-011352.md) | [0.7 d](/filings/0001437749-22-020159.md) | [0.7 d](/filings/0001437749-22-026222.md) | [0.7 d](/filings/0001437749-23-006386.md) |
| Share repurchases | $m | not reported | not reported | not reported | [0.0 d](/filings/0001437749-23-006386.md) | [0.0](/filings/0001437749-22-011352.md) | not reported | not reported | [(0.3) d](/filings/0001437749-23-006386.md) | [0.1](/filings/0001437749-22-011352.md) | [0.0 d](/filings/0001437749-22-020159.md) | [0.9 d](/filings/0001437749-22-026222.md) | [1.8 d](/filings/0001437749-23-006386.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2019 (2019-03-31) | Q2 FY2019 (2019-06-30) | Q3 FY2019 (2019-09-30) | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,278](/filings/0001437749-20-010101.md) | [3,272](/filings/0001437749-20-016525.md) | [3,273](/filings/0001437749-20-022120.md) | [3,270](/filings/0001437749-21-010761.md) | [3,271](/filings/0001437749-21-018379.md) | [3,275](/filings/0001437749-21-024933.md) | [3,311](/filings/0001437749-22-011352.md) | [3,335](/filings/0001437749-22-020159.md) | [3,313](/filings/0001437749-22-026222.md) | [3,335](/filings/0001437749-22-011352.md) | [3,330](/filings/0001437749-22-020159.md) | [3,278](/filings/0001437749-22-026222.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,136,180 at 2023-02-28, from the cover of the [10-K filed 2023-03-13](/filings/0001437749-23-006386.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.